Skip to content

NeuroN-QI: An Intervention to Promote Preterm Infants' Neurodevelopment

Effects of a Parent-preterm Proximity and Calm Intervention (NeuroN-QI) on the Neurodevelopment of Preterm Infants: A Randomized Pragmatic Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06087744
Enrollment
124
Registered
2023-10-18
Start date
2023-11-23
Completion date
2027-10-31
Last updated
2024-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodevelopmental Disorders

Keywords

NICU, skin to skin contact, neurodevelopment, preterm infants, positive stimulation, environmental control

Brief summary

NeuroN-QI aims to evaluate the effects of an intervention consisting of periods of: 1) parents/preterm infants skin-to-skin contact and auditory stimulation by the parents's voice and 2) calm without manipulation with olfactory stimulation with breast milk in the incubator/bed both combined with appropriate light and noise levels to promote neurodevelopment preterm infants.

Interventions

BEHAVIORALNeuroN-QI

Skin-to-skin contact (SSC) lasting 2 hours with an auditory sensory stimulation followed by a period of calm and rest of one hour during which the infants will rest in their incubator with breast milk's olfactory stimulation. Light and sound control will be done during the entire intervention.

BEHAVIORALSSC alone

Skin-to-skin contact (SSC) lasting 2 hours

Sponsors

St. Justine's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
24 Weeks to 34 Weeks
Healthy volunteers
No

Inclusion criteria

for preterm infants: * born between 24 and 33 6/7 weeks GA; * ready for SSC Inclusion criteria for mothers and fathers: * agree to do at least one SSC session/week combined with 10 min of auditory stimulation until 36 weeks of GA of their preterm infant; * mothers express breast milk for their preterm infants For twin births (twin pregnancies), fathers will also be invited to participate in the study, so that both infants can participate in the study.

Exclusion criteria

for preterm infants: * congenital anomalies or genetic disorders * intraventricular hemorrhage \> grade II * are small for GA defined as birth weight \<10th percentile * on postnatal day 19 (maximum days targeted for study start) * are still receiving analgesics, sedatives, paralyzing agents * are under mechanical ventilation

Design outcomes

Primary

MeasureTime frameDescription
Neurodevelopment36 weeks gestational age (GA)Recording with video and coding with Assessment of Behavioral Systems Organization (ABSO) (from Assessment of Preterm Infant Behavior (APIB))

Secondary

MeasureTime frameDescription
Parental StressBaseline before randomization and every week after until 36 weeks GAQuestionnaire - Parental Stress Scale - Neonatal Intensive Care Unit (NICU) (PSS:NICU) - 25 items with a 5-point Likert-type. Minimum value: 25, maximum value: 100. A higher score indicates higher parental stress.
Parental AnxietyBaseline before randomization and every week after until 36 weeks GAQuestionnaire - State-Trait Anxiety Inventory (STAI) - 20 items with a 4-point Likert-type scale. Minimum value: 20; maximum value: 80. A higher score indicates higher anxiety.
Neurodevelopment4 months and 18 monthsCerebral discontinuity activity vs. activity with EEG
Milk productionEvery day in mL until study completion at infants' 36 weeks gestational age.Through diary
Milk consumptionTotal in mL until study completion at infants' 36 weeks gestational age.Through charting
Parental sensitivity4 months ans 18 monthsRecording through videos and coding with Welch Emotional Connection Screen (WECS) - 4 dimensions: mutual attraction, facial communication, vocal communication and sensitivity/reciprocity are coded on a 9-point scale from 1 to 3. Minimum value 4; maximum value 12. Higher scores indicate a better mother-child emotional connection.

Countries

Canada

Contacts

Primary ContactMarilyn Aita, Ph.D.
marilyn.aita@umontreal.ca514-343-6111
Backup ContactKate St-Arneault, Ph.D (cand.)
kate.st-arneault.hsj@ssss.gouv.qc.ca

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026